United Therapeutics (UTHR) Gross Margin (2009 - 2026)
United Therapeutics (UTHR) posted Gross Margin of 87.30% for Q2 2026, down 1.73 percentage points from 89.03% a year earlier but up 4.37 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Gross Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at United Therapeutics was 86.14%, down 2.84 percentage points year-over-year; for FY2025, it was 87.92%, down 1.31 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -4.79 percentage points (FY2020 to FY2025).
- In prior years, United Therapeutics' Gross Margin was 89.24% in FY2024 (+0.30 pp), 88.94% in FY2023 (-3.23 pp), 92.17% in FY2022 (-0.56 pp) and 92.73% in FY2021 (+0.02 pp).
- Quarterly Gross Margin has run from a low of 82.93% in Q1 2026 to a high of 94.39% in Q1 2022 over five years.
- On a year-over-year basis, Gross Margin has declined in each of the last six quarters, with an average year-over-year change of -1.35 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2022, with a gain of 1.97 percentage points; the weakest was Q1 2026, with a drop of 5.43 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 82.93% (Q1 2026), 86.91% (Q4 2025) and 87.38% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 87.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.30% |
| Mar 31, 2026 | 82.93% |
| Dec 31, 2025 | 86.91% |
| Sep 30, 2025 | 87.38% |
| Jun 30, 2025 | 89.03% |
| Mar 31, 2025 | 88.36% |
| Dec 31, 2024 | 89.69% |
| Sep 30, 2024 | 88.90% |
| Jun 30, 2024 | 89.12% |
| Mar 31, 2024 | 89.24% |
| Dec 31, 2023 | 88.45% |
| Sep 30, 2023 | 88.50% |
| Jun 30, 2023 | 89.25% |
| Mar 31, 2023 | 89.68% |
| Dec 31, 2022 | 88.04% |
| Sep 30, 2022 | 92.79% |
| Jun 30, 2022 | 93.64% |
| Mar 31, 2022 | 94.39% |
| Dec 31, 2021 | 91.67% |
| Sep 30, 2021 | 93.77% |
API Access
United Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();